CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.340
-0.180 (-7.14%)
Oct 29, 2024, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $27.00 million as of October 29, 2024. Its market cap has decreased by -33.65% in one year.
Market Cap
27.00M
Enterprise Value
22.29M
1-Year Change
-33.65%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $27.00M, a decrease of -41.45%. That is a compound annual growth rate of -29.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 29.50M | -47.79% |
| Dec 29, 2023 | 56.50M | 22.51% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroGen | 30.00M |
| Onconetix | 29.70M |
| Lipocine | 29.68M |
| MiNK Therapeutics | 29.62M |
| Femasys | 29.57M |
| Curis | 29.42M |
| Burning Rock Biotech | 29.24M |
| Outset Medical | 28.85M |